methylnitrosourea has been researched along with Di Guglielmo Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sun-Hoffman, L; Winicov, I | 1 |
| Chun, HG; Cradock, J; Davignon, P; Grieshaber, C; Hoth, D; Leyland-Jones, B; Moon, R; Rifkind, R; Shoemaker, D; Wolpert-DeFilippes, M | 1 |
1 review(s) available for methylnitrosourea and Di Guglielmo Disease
| Article | Year |
|---|---|
Hexamethylene bisacetamide: a polar-planar compound entering clinical trials as a differentiating agent.
Topics: Acetamides; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Differentiation; Cell Line; Cyclophosphamide; Dogs; Drug Evaluation, Preclinical; Humans; Kinetics; Leukemia, Erythroblastic, Acute; Leukemia, Myeloid; Mammary Neoplasms, Experimental; Methylnitrosourea; Mice; Neoplasms; Rats; Tumor Stem Cell Assay | 1986 |
1 other study(ies) available for methylnitrosourea and Di Guglielmo Disease
| Article | Year |
|---|---|
MNU affects mouse erythroleukemia cell differentiation at sub-cytotoxic doses.
Topics: Animals; Blotting, Northern; Carcinogens; Cell Count; Cell Differentiation; Dimethyl Sulfoxide; Gene Expression Regulation; Globins; Leukemia, Erythroblastic, Acute; Methylnitrosourea; Mice; Mice, Inbred DBA; Recombinant Proteins; RNA, Neoplasm; Time Factors; Transcription, Genetic; Tumor Cells, Cultured | 1996 |